LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -5.9% | 188 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -43.3% | 188 | -29.9% | 0.00% | -50.0% |
| Q1 2022 | $30,000 | -26.8% | 268 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $41,000 | +10.8% | 268 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $37,000 | +5.7% | 268 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $35,000 | -12.5% | 268 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $40,000 | +14.3% | 268 | -24.7% | 0.01% | 0.0% |
| Q4 2020 | $35,000 | – | 356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |